Research map: Chronic Myelomonocytic Leukemia: History, Pathobiology, Diagnostic Controversies, and Evolving Classification

Back to the article

Papers in this map

  1. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia · Daniel A. Arber · 2016 · 10386 citations · Cited by this paper
  2. Prognostic and Predictive Models in Myelofibrosis · 2024 · Related
  3. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes · James W. Vardiman · 2009 · 4459 citations · Cited by this paper
  4. Molecular Pathogenesis and Targeted Therapies for Myeloproliferative Hypereosinophilic Neoplasms · 2026 · Related
  5. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms · Joseph David Khoury · 2022 · 4220 citations · Cited by this paper
  6. Splicing Factor Mutations in Chronic Myelomonocytic Leukemia: Biological Consequences and Therapeutic Implications · 2025 · Related
  7. Proposals for the classification of the myelodysplastic syndromes · John M. Bennett · 1982 · 3674 citations · Cited by this paper
  8. From MRD To Match: the Role of Allogeneic Hematopoietic Cell Transplant in Philadelphia-Negative B-ALL · 2025 · Related
  9. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN · Hartmut Döhner · 2022 · 3298 citations · Cited by this paper
  10. How Do We Manage Chronic Lymphocytic Leukemia in India · 2024 · Related
  11. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data · Daniel A. Arber · 2022 · 2919 citations · Cited by this paper
  12. Glucocorticoid Therapy in Acute Lymphoblastic Leukemia: Navigating Short-Term and Long-Term Effects and Optimal Regimen Selection · 2024 · Related
  13. The World Health Organization (WHO) classification of the myeloid neoplasms · James W. Vardiman · 2002 · 2198 citations · Cited by this paper
  14. Novel Approaches to Managing Patients with Relapsed and Refractory Waldenström Macroglobulinemia · 2024 · Related
  15. Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia · Chiara Elena · 2016 · 367 citations · Cited by this paper
  16. Maintenance Therapy Post-Stem Cell Transplantation for Patients with T-Cell Lymphomas · 2024 · Related
  17. Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia · Esperanza Such · 2013 · 319 citations · Cited by this paper
  18. Allogeneic Transplant for CMML · 2025 · Related
  19. ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients · Mrinal M. Patnaik · 2014 · 284 citations · Cited by this paper
  20. Transplantation and Cellular Therapy for Older Adults—The MSK Approach · 2024 · Related
  21. Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia · Dorothée Selimoglu‐Buet · 2015 · 264 citations · Cited by this paper
  22. Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to Venetoclax · Joan Montero · 2016 · 216 citations · Cited by this paper
  23. TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow · Khaled M. Alayed · 2013 · 143 citations · Cited by this paper
  24. DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality · Kitsada Wudhikarn · 2020 · 142 citations · Cited by this paper
  25. Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions · Peter Valent · 2019 · 140 citations · Cited by this paper
  26. Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia · Mrinal M. Patnaik · 2016 · 137 citations · Cited by this paper
  27. Morphological evaluation of monocytes and their precursors · Jean-Etienne Goasguen · 2009 · 130 citations · Cited by this paper
  28. Specific Skin Lesions in Chronic Myelomonocytic Leukemia · Franck Vitte · 2012 · 128 citations · Cited by this paper
  29. NPM1 mutations define a specific subgroup of MDS and MDS/MPN patients with favorable outcomes with intensive chemotherapy · Guillermo Montalban Bravo · 2019 · 114 citations · Cited by this paper
  30. Chronic myelomonocytic leukemia: the role of bone marrow biopsy immunohistology · Attilio Orazi · 2006 · 111 citations · Cited by this paper
  31. RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis · Ryan Michael Carr · 2021 · 104 citations · Cited by this paper
  32. Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemia · Nolwenn Lucas · 2019 · 102 citations · Cited by this paper
  33. Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)—a study of 1084 patients · Giacomo Coltro · 2019 · 102 citations · Cited by this paper
  34. Dual Expression of TCF4 and CD123 Is Highly Sensitive and Specific For Blastic Plasmacytoid Dendritic Cell Neoplasm · Narittee Sukswai · 2019 · 94 citations · Cited by this paper
  35. Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management · Mrinal M. Patnaik · 2024 · 90 citations · Cited by this paper
  36. Molecular taxonomy of myelodysplastic syndromes and its clinical implications · Elsa Bernard · 2024 · 84 citations · Cited by this paper
  37. Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia · Julia Turbiner Geyer · 2017 · 78 citations · Cited by this paper
  38. Accumulation of classical monocytes defines a subgroup of MDS that frequently evolves into CMML · Dorothée Selimoglu‐Buet · 2017 · 77 citations · Cited by this paper
  39. DNMT3A mutations are associated with inferior overall and leukemia‐free survival in chronic myelomonocytic leukemia · Mrinal M. Patnaik · 2016 · 75 citations · Cited by this paper

Source: OpenAlex (CC0)